Related Experiment Video
Updated: May 13, 2025

Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing
Published on: October 15, 2014
How to avoid time-related types of bias in the analysis of clinical infectious diseases: demonstration and methods
Derek Hazard1, Marlon Grodd1, Dietrich Walzer2
1Institute of Medical Biometry and Statistics, Medical Faculty and Medical Center - University of Freiburg, Freiburg, Germany.
Background:
Competing risk and immortal time bias can significantly affect the interpretation of analyses in infection disease research where patients may experience multiple outcomes. These biases can distort study results, leading to misestimation of event rates or therapy effects, and ultimately misinform clinical decisions.
Objective:
This article aims to explain the concepts of competing risk and immortal time bias while providing a clear understanding of how these biases arise and offering practical methods for addressing them in clinical studies. A study of patients in the intensive care unit (ICU) is used as an illustrative example.
Sources:
References were compiled through searches of MEDLINE/PubMed and Google Scholar up to December 2024.
Content:
Competing risk bias occurs when a patient is at risk for more than one mutually exclusive event, such as death from different causes, which can skew survival analyses if not properly accounted for. Immortal time bias arises when periods during which the outcome cannot occur for patients with an intermediate exposure are improperly included in a survival analysis. This leads to altered effects and duration of stay estimation. In the ICU data example, ignoring competing risks results in impossible probability estimates and relative overestimation of incidence by as much as 52%. Ignoring time dependencies leads to the flawed conclusion that bloodstream infection is protective against patient death in the ICU, whereas a valid approach results in a significant harmful effect. Solutions such as multi-state models or extended Cox regression models are presented to mitigate these biases. Examples from published literature with proper handling of these biases are provided.
Implications:
Properly accounting for competing risk and immortal time biases ensures more reliable and valid results, ultimately guiding better clinical decision-making and improving patient outcomes in the management of infectious diseases.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Assumptions of Survival Analysis
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Steps in Outbreak Investigation

